Page data last changed: . Chemistry registry snapshot: . Registry refreshes and identity assessments are separate from scientific content review.
Classic GHRP used in GH-axis research and older clinical diagnostics.
Also known as: pralmorelin · GHRP2
Part of the Growth hormone & IGF peptides cluster
Overview
GHRP-2 (pralmorelin) is a synthetic growth hormone–releasing peptide that acts at the ghrelin receptor. It is a foundational compound in GH secretagogue research education.
Source & context
Biological / chemical source: Synthetic hexapeptide
Primary research or clinical context: Research compound; pralmorelin has diagnostic uses in some countries
GHRP family
GHRP-2 sits alongside GHRP-6, hexarelin, and ipamorelin in the growth hormone secretagogue conversation. Selectivity and side-effect profiles differ across the class.
Research framing
Literature examines GH release, appetite signaling, and receptor pharmacology. Online protocols are not a substitute for controlled research design or medical care.
Sequence
One-letter sequence commonly cited for GHRP-2 (educational; isoforms and modifications may differ):
AAAWFK
Residues plotted ~100° apart around an α-helix — clustering of one color reveals an amphipathic face.
Structure & chemistry
Molecular identity & reference confidence
Source-supported reference
Reference values are taken from the cited molecular record or curated profile. A database match is not independent laboratory verification; modifications, counter-ions, and formulations can change the measured mass.
- Molecular form
- GHRP-2 (source record; form not independently established)
- Species
- Not established by this molecular identity audit
- Termini (N / C)
- Not specified / Not specified
Average reference mass
Reference policy updated: 2026-10-05
- IUPHAR/BPS source snapshot · 2026-10-01
- PubChem molecular record · 2026-10-01
- Molecular formula
- C45H55N9O6
- Average reference mass
- ≈ 818
- Status
- Approved medicine in at least one jurisdiction (IUPHAR record)
C-terminal lysine is amidated; alanine residue at position 2 is 2-naphthalenyl-alanine (Nal)
- PubChem CID: 6918245
- IUPHAR ligand: 1092
- ChEMBL: CHEMBL106593
- CAS RN: 158861-67-7
- UNII: E6S6E1F19M
Chemistry values: IUPHAR/BPS Guide to Pharmacology, PubChem · fetched 2026-10-01.
GHRP-2 — reconstitution calculator
Enter how much peptide is in the vial and how much diluent (e.g. bacteriostatic water) is added. The tool returns the resulting solution concentration — and, for any amount you type, the volume it corresponds to. This is educational arithmetic, not a dosing recommendation.
Reference form: GHRP-2 (source record; form not independently established)Average reference mass: 818 Da
Enter an amount to see the volume it corresponds to.
Educational concentration mathematics only. This tool does not recommend a dose, amount, or protocol, and nothing here is medical advice. Many peptides are not authorized by Health Canada for human use — see our reconstitution and bacteriostatic-water guides for context.
FAQ about GHRP-2
What is GHRP-2?+
GHRP-2 (pralmorelin) is a synthetic growth hormone–releasing peptide that acts at the ghrelin receptor. It is a foundational compound in GH secretagogue research education.
What Canadian product status is recorded for GHRP-2?+
Canadian product status for GHRP-2 has not been verified in this profile. No verified record here does not mean no authorization exists. Status depends on the product, formulation and use; consult Health Canada's product records.
What is the typical length of GHRP-2?+
GHRP-2 is commonly described as approximately 6 amino acids (Research peptide).
Related peptides
References & further reading
- 1.Okano et al. (2010). Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom
- 2.Doi et al. (2004). Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide. Arzneimittelforschung
- 3.Laferrère et al. (2005). Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. J Clin Endocrinol Metab
- 4.Hayakawa et al. (2018). Evaluation of Hypothalamic-Pituitary-Adrenal Axis by the GHRP2 Test: Comparison With the Insulin Tolerance Test. J Endocr Soc
- 5.Semenistaya et al. (2015). Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin. Drug Test Anal
- 6.Popławska et al. (2019). Identification of a novel growth hormone releasing peptide (a glycine analogue of GHRP-2) in a seized injection vial. Drug Test Anal
- 7.Granado et al. (2005). Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Am J Physiol Endocrinol Metab
- 8.Chen et al. (1998). Growth hormone-releasing peptide-2 (GHRP-2) does not act via the human growth hormone-releasing factor receptor in GC cells. Endocrine
- 9.PubChem — compound summary for Pralmorelin / GHRP-2 (CID 6918245)
- 10.Wikipedia — Pralmorelin (GHRP-2)